Safety check The right choice can change based on history, medication interactions, side effects, budget, and availability
Typically, common side effects like nausea, stomach discomfort, or headache may appear early on and often improve within a few weeks as your body adjusts to the medication
Abstract This large community-based cohort study investigates the impact of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), specifically Liraglutide and Semaglutide, on the risk of developing psychiatric conditions such as depression, anxiety, and suicidal behaviors in patients with obesity
As always, this conversation blends physiology, research, and real-world coaching experience so you can better understand what actually drives sustainable results
In a trial of semaglutide, people who switched to a placebo regained around 7% of their body weight over the following year, while those who kept taking the medication lost a further 8%